3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Pancreatic Neoplasms
10
Colorectal Neoplasms
10
Neoplasm Metastasis
7
Neuroblastoma
4
Rhabdomyosarcoma
3
Lung Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Neuroendocrine
2
Biliary Tract Neoplasms
2
Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Refractory Solid Tumors
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Medulloblastoma
1
Malignant mesenchymal tumor
1
Intestinal Neoplasms
1
Gastrointestinal Neoplasms
1
Interventions
Rituximab
17
Cyclophosphamide
15
Prednisone
12
Doxorubicin
10
Lenalidomide
9
ibrutinib
7
Vincristine
7
polatuzumab vedotin
5
obinutuzumab
5
Oxaliplatin
5
Magnetic Resonance Spectroscopy
5
Gemcitabine
5
venetoclax
4
glofitamab
4
fludarabine
4
Specimen Handling
4
Biopsy
4
prednylidene
3
fludarabine phosphate
3
deltacortene
3
Whole-Body Irradiation
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Bendamustine Hydrochloride
3
zanubrutinib
2
pembrolizumab
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Irinotecan
×
30 days
×
Clear all
No trials found.